Fumito Ito, MD, PhD on CX3CR1–CD8+ T-cells @RoswellPark

Fumito Ito, MD, PhD on CX3CR1–CD8+ T-cells @RoswellPark

Cancer-News

1 month
16 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Fumito Ito, MD, PhD of Roswell Park @RoswellPark discusses CX3CR1–CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment.

Read here: https://insight.jci.org/articles/view/133920?utm_source=Cision&utm_medium=Email&utm_term=Apr-20%60&utm_content=cancer%2c+melanoma%2c+prostate%2c+pancreatic%2c+rectal%2c+treatment%2c+studies%2c+research

Up Next Autoplay